dipyridamole and acivicin

dipyridamole has been researched along with acivicin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Alberti, D; Bruggink, J; Earhart, RH; Fischer, PH; Hamilton, RD; Koeller, JM; Simon, K; Tormey, DC; Tutsch, K; Willson, JK1
Bruggink, J; Fischer, PH; Ranhosky, A; Risueno, C; Trump, DL; Tutsch, K; Willson, JK1
Faderan, MA; Lui, MS; Natsumeda, Y; Weber, G1
Bittner, G; Fischer, PH; Pamukcu, R; Willson, JK1
Lui, MS; Weber, G; Zhen, YS1

Other Studies

7 other study(ies) available for dipyridamole and acivicin

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
    Cancer research, 1988, Oct-01, Volume: 48, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Dipyridamole; Drug Evaluation; Humans; Isoxazoles; Leukocyte Count; Metabolic Clearance Rate; Neoplasms; Nucleosides

1988
Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
    Cancer research, 1988, Oct-01, Volume: 48, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon-Nitrogen Ligases; Dipyridamole; Drug Evaluation; Humans; Infusions, Intravenous; Isoxazoles; Ligases; Nucleosides

1988
Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Advances in enzyme regulation, 1983, Volume: 21

    Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; Guanine Deaminase; Hypoxanthine Phosphoribosyltransferase; Isoxazoles; Liver; Liver Neoplasms, Experimental; Pentosyltransferases; Purine Nucleotides; Pyrimidines; Rats; Xanthine Oxidase

1983
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
    Cancer research, 1984, Volume: 44, Issue:8

    Topics: Antibiotics, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Isoxazoles; Kinetics; Oxazoles; Ribonucleosides; Ribonucleotides

1984
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Cancer research, 1983, Volume: 43, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides

1983